HCA Healthcare, Inc. - Common Stock, par value $0.01 per share (HCA) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.01 per share
Symbol
HCA on NYSE
Shares outstanding
223,277,184
Price per share
$464.38
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
134,874,131
Total reported value
$62,947,627,113
% of total 13F portfolios
0.04%
Share change
-2,925,812
Value change
-$1,282,745,571
Number of holders
1,354
Price from insider filings
$464.38
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of HCA Healthcare, Inc. - Common Stock, par value $0.01 per share (HCA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Frisco Holding II 32% $33,818,705,399 70,555,590 Thomas F. Frist, Jr. 06 Feb 2026
BlackRock, Inc. 4.9% $4,064,772,478 12,133,287 BlackRock, Inc. 31 Mar 2025

As of 31 Dec 2025, 1,354 institutional investors reported holding 134,874,131 shares of HCA Healthcare, Inc. - Common Stock, par value $0.01 per share (HCA). This represents 60% of the company’s total 223,277,184 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of HCA Healthcare, Inc. - Common Stock, par value $0.01 per share (HCA) together control 40% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 6.6% 14,716,173 -1.2% 0.1% $6,870,392,526
BlackRock, Inc. 5.6% 12,581,087 +0.91% 0.1% $5,873,606,176
Sanders Capital, LLC 4.7% 10,464,168 -2% 5.6% $4,885,301,472
STATE STREET CORP 3.4% 7,566,643 +1% 0.12% $3,532,562,951
Capital World Investors 2.2% 4,999,422 +0.81% 0.32% $2,334,040,379
FMR LLC 1.7% 3,833,373 +101% 0.09% $1,789,648,890
GEODE CAPITAL MANAGEMENT, LLC 1.6% 3,663,705 +0.37% 0.11% $1,702,737,640
First Eagle Investment Management, LLC 1.6% 3,646,152 -7% 3% $1,702,242,719
WELLINGTON MANAGEMENT GROUP LLP 1.5% 3,423,986 -12% 0.28% $1,598,522,103
NORGES BANK 1.2% 2,704,265 0.14% $1,262,513,158
JPMORGAN CHASE & CO 1.1% 2,359,220 -21% 0.07% $1,101,425,769
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1% 2,311,112 +12% 0.63% $1,078,965,748
MORGAN STANLEY 0.98% 2,194,522 +3% 0.06% $1,024,535,446
GOLDMAN SACHS GROUP INC 0.79% 1,771,281 -2.3% 0.12% $826,940,675
NORTHERN TRUST CORP 0.79% 1,763,267 -3.1% 0.1% $823,198,832
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 0.7% 1,559,356 -9.2% 0.15% $728,000,943
BARCLAYS PLC 0.59% 1,322,211 +7.4% 0.25% $617,287,427
FRANKLIN RESOURCES INC 0.55% 1,234,371 +5.2% 0.14% $576,278,411
Nuveen, LLC 0.51% 1,138,972 -25% 0.14% $531,740,468
Invesco Ltd. 0.51% 1,138,179 +3.4% 0.08% $531,370,306
UBS Group AG 0.5% 1,105,776 -31% 0.1% $516,242,584
JANUS HENDERSON GROUP PLC 0.49% 1,089,890 -12% 0.23% $508,820,625
NORDEA INVESTMENT MANAGEMENT AB 0.49% 1,084,590 +11% 0.44% $507,392,894
Legal & General Group Plc 0.48% 1,075,537 -4.4% 0.11% $502,125,205
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.48% 1,068,710 -1.5% 0.08% $498,937,951

Institutional Holders of HCA Healthcare, Inc. - Common Stock, par value $0.01 per share (HCA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 134,874,131 $62,947,627,113 -$1,282,745,571 $466.86 1,354
2025 Q3 136,798,854 $58,284,756,303 -$4,122,994,665 $426.20 1,278
2025 Q2 146,598,810 $56,127,057,771 -$1,853,153,800 $383.10 1,239
2025 Q1 152,192,884 $52,564,357,865 -$2,006,251,000 $345.55 1,214
2024 Q4 158,412,925 $47,557,475,465 -$8,742,290 $300.15 1,169
2024 Q3 157,628,473 $63,992,248,095 -$2,602,260,628 $406.43 1,192
2024 Q2 163,570,360 $52,579,318,347 -$183,070,166 $321.28 1,151
2024 Q1 163,721,760 $54,559,435,398 -$1,094,106,832 $333.53 1,116
2023 Q4 168,060,091 $45,488,018,617 -$285,213,231 $270.68 1,047
2023 Q3 169,154,472 $41,607,918,680 -$1,185,806,069 $245.98 989
2023 Q2 173,400,079 $52,556,079,546 -$666,679,406 $303.48 1,006
2023 Q1 175,196,823 $46,186,378,435 -$839,492,963 $263.68 958
2022 Q4 179,614,269 $43,106,998,862 -$1,135,008,361 $239.96 949
2022 Q3 184,870,749 $34,004,075,333 -$752,760,047 $183.79 849
2022 Q2 188,490,291 $31,685,644,085 -$1,589,511,131 $168.06 854
2022 Q1 198,438,957 $49,759,228,094 -$1,674,801,898 $250.62 950
2021 Q4 204,993,837 $52,647,373,530 -$1,558,591,258 $256.92 931
2021 Q3 210,742,269 $51,162,204,632 -$2,696,772,377 $242.72 870
2021 Q2 221,449,830 $45,771,072,350 -$1,473,962,964 $206.74 805
2021 Q1 231,377,874 $43,551,161,088 -$1,184,824,119 $188.34 777
2020 Q4 237,137,952 $38,991,278,461 +$223,535,805 $164.46 765
2020 Q3 237,038,075 $29,542,477,145 +$374,442,548 $124.68 709
2020 Q2 233,611,421 $22,662,190,032 +$114,158,905 $97.06 676
2020 Q1 233,576,916 $20,985,688,732 -$500,973,286 $89.85 691
2019 Q4 237,576,726 $35,070,820,741 +$69,075,392 $147.81 707
2019 Q3 237,425,759 $28,552,762,563 -$390,813,393 $120.42 668
2019 Q2 240,503,276 $32,450,213,560 +$200,307,836 $135.17 666
2019 Q1 242,859,071 $31,613,110,993 -$72,604,081 $130.38 692
2018 Q4 243,226,790 $30,217,039,773 -$151,772,142 $124.45 691
2018 Q3 244,050,841 $33,880,893,815 -$405,124,383 $139.12 649
2018 Q2 247,244,952 $25,314,355,349 -$453,682,956 $102.60 640
2018 Q1 251,241,956 $24,303,990,209 -$605,356,676 $97.00 607
2017 Q4 257,576,538 $22,569,606,948 -$1,125,863,838 $87.84 557
2017 Q3 270,067,721 $21,491,862,815 +$432,919 $79.59 523
2017 Q2 269,733,979 $23,523,687,954 -$283,225,148 $87.20 565
2017 Q1 273,801,978 $24,364,900,598 +$1,921,669,692 $88.99 569
2016 Q4 273,996,527 $20,276,620,099 +$125,377,695 $74.02 565
2016 Q3 271,673,421 $20,535,113,085 -$512,554,258 $75.63 577
2016 Q2 277,691,100 $21,385,005,482 -$925,974,468 $77.01 606
2016 Q1 289,930,780 $22,623,817,519 -$261,940,529 $78.05 581
2015 Q4 296,382,283 $20,045,696,881 -$1,056,897,195 $67.63 575
2015 Q3 309,503,569 $23,938,836,528 -$349,165,270 $77.36 630
2015 Q2 313,081,744 $28,402,056,579 -$595,630,068 $90.72 651
2015 Q1 321,227,970 $24,164,161,122 +$211,563,363 $75.23 591
2014 Q4 318,310,377 $23,361,922,697 -$834,223,912 $73.39 540
2014 Q3 329,453,347 $23,233,763,725 +$543,310,103 $70.52 499
2014 Q2 323,509,963 $18,244,634,062 -$766,287,989 $56.38 437
2014 Q1 337,917,820 $17,736,335,008 +$311,154,994 $52.50 399